1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

TherapeuticsMD Inc (TXMD) Files 10-K for the Fiscal Year Ended on December 31, 2017

February 23, 2018 | About:

TherapeuticsMD Inc (NASDAQ:TXMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product. TherapeuticsMD Inc has a market cap of $1.16 billion; its shares were traded at around $5.37 with and P/S ratio of 66.29. TherapeuticsMD Inc had annual average EBITDA growth of 9.00% over the past five years.

For the last quarter TherapeuticsMD Inc reported a revenue of $4.12 million, compared with the revenue of $4.49 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $16.8 million, a decrease of 13.3% from the previous year. For the last five years TherapeuticsMD Inc had an average revenue growth rate of 33.3% a year.

The reported loss per diluted share was 37 cents for the year, compared with the loss per share of $0.22 in the previous year. The TherapeuticsMD Inc had an operating margin of -462.68%, compared with the operating margin of -466.28% a year before. The 10-year historical median operating margin of TherapeuticsMD Inc is -422.93%. The profitability rank of the company is 6 (out of 10).

At the end of the fiscal year, TherapeuticsMD Inc has the cash and cash equivalents of $127.1 million, compared with $131.5 million in the previous year. The company had no long term debt. The interest coverage to the debt is 1.8, which is not a favorable level. TherapeuticsMD Inc has a financial strength rank of 9 (out of 10).

At the current stock price of $5.37, TherapeuticsMD Inc is traded at 31.9% premium to its historical median P/S valuation band of $4.07. The P/S ratio of the stock is 66.29, while the historical median P/S ratio is 50.21. The stock lost 11.64% during the past 12 months.

For the complete 20-year historical financial data of TXMD, click here.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

HOLKLSUTop 20 Group Q3 2018 SHUT Sect
HOLKLSUEquity Income Group Q3 2018 SH
blovedayBest Backtest Results
ralphdQuality Growth
salvatore34stock screener 2.0
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat